Taiwan FDA registration de5057580caf92fbad04880dbabace75
In vitro reagents for new pregnancy tests
TW: 新情驗孕體外試劑
Taiwan·Risk Class 2·Longteng Biotech Co., Ltd. Xinshi Plant;; Liguo Pharmaceutical Co., Ltd·Registered Apr 10, 2019 – Oct 26, 2028ActiveRegistration details
- Analysis ID
- de5057580caf92fbad04880dbabace75
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Liguo Pharmaceutical Co., Ltd
Product details
- Intended Use
- This product qualitatively detects human chorionic gonadotropins in human urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Domestic;; Contract manufacturing
Dates and status
- Registration Date
- Apr 10, 2019
- Expiry Date
- Oct 26, 2028
About this record
Access comprehensive regulatory information for In vitro reagents for new pregnancy tests in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number de5057580caf92fbad04880dbabace75 and manufactured by Longteng Biotech Co., Ltd. Xinshi Plant;; Liguo Pharmaceutical Co., Ltd. The authorized representative in Taiwan is Liguo Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices